Dr. Alencar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
CRB - Clinical Research Building
1120 NW 14th Street, Suite 610H
Miami, FL 33136Phone+1 305-243-4372Fax+1 305-243-9161
Clinical Expertise
- Malignant Hematology, Hematologic oncology, Oropharyngeal lymphoma, Angiocentric lymphoma, Non-Hodgkin lymphoma, Acute lymphoid leukemia, Primary intraocular lymphoma, Hodgkin's lymphoma
Education & Training
- University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2006 - 2009
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2003 - 2006
- OtherClass of 2002
Certifications & Licensure
- FL State Medical License 2012 - 2026
- NM State Medical License 2009 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies Start of enrollment: 2013 Mar 14
- Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Feb 05
Publications & Presentations
PubMed
- 236 citationsPirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Yoon Cheah, John M. Pagel
Lancet. 2021-03-06 - 54 citationsPirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.Anthony R Mato, Jennifer A Woyach, Jennifer R Brown, Paolo Ghia, Krish Patel
The New England Journal of Medicine. 2023-07-06 - 92 citationsCardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sézary syndromeDaniel J. Lenihan, Alvaro J. Alencar, Deborah Yang, Razelle Kurzrock, Michael J. Keating
Blood. 2004-08-01
Press Mentions
- Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip SheetNovember 13th, 2024
- Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition – Tip SheetNovember 13th, 2024
- Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Spanish, French, Italian, Portuguese
External Links
- Sylvester Comprehensive Cancer Centerhttp://uhealthsystem.com/doctors/profile/97420
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: